Table 3 Quality assessment results of evidence used based on the hierarchy of data sources by Cooper et al. [12]
Input parameters | Hierarchy of data sources | % Agreement* | |||||||
|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 9 | # | ||
Clinical effect sizes | 16 (27%) | 0 | 0 | 29 (49%) | 0 | 2 (3%) | 4 (7%) | 8 (14%) | 85 |
Baseline clinical data | 4 (7%) | 1 (2%) | 0 | 51 (85%) | 1 (2%) | 1 (2%) | 1 (2%) | Â | 81 |
Resource use | 7 (12%) | 51 (86%) | 0 | 0 | 0 | 1 (2%) | 0 | Â | 92 |
Costs | 6(10%) | 53 (90%) | 0 | 0 | 0 | 0 | 0 | Â | 85 |
Utility | 2(5%) | 0 | 38 (93%) | 1 (2%) | 0 | 0 | 0 | Â | 97 |